Our Products
By utilizing multiple botanical ingredients for achieving a multiple-target approach, combined with unique drug delivery technology, we have developed two botanical drugs (PCH and HTB) for treating prostate cancer and hepatitis B. Options for both diseases are considered unmet clinical needs.
PCH – For treating prostate cancer
HTB – For treating hepatitis B
The company is pursuing the FDA’s drug approval for these two botanical drug products.
